Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
July 24, 2006
By: Tim Wright
Editor-in-Chief, Contract Pharma
Czura Thornton Ltd. has acquired Chiltern International for an undisclosed amount. Czura Thornton, a private investment group led by Antony Czura and Nick Thornton, has acquired more than 90% of Chiltern, a global CRO, with the remainder expected to be acquired over the next few weeks. Chiltern runs national and international Phase I to Phase IV trials across a broad range of therapeutic areas. The company has offices throughout the U.S., Europe and India, with headquarters in Slough, UK, and Carlsbad, CA. Chiltern provides clinical operations, project management, bio-analytical, data management, biostatistics, medical writing, quality assurance and regulatory and medical affairs services to the pharmaceutical, biopharmaceutical and medical device industries. The company also offers clinical contract personnel services. Simon Garnham, co-founder of Chiltern, will step down as chief executive officer effective immediately. A new chief executive will be announced soon. Nick Thornton, who has been named executive vice chairman, will also act as chief executive until the announcement. Roland Boyd has been appointed chief financial officer. “We have long admired Chiltern’s reputation in the industry for providing a comprehensive range of high quality products and excellent customer service,” said Mr. Thornton. “We look forward to bringing the investment and resources needed for the next phase of the Company’s growth as a leading, global, full-service clinical CRO. We are committed to ensuring a smooth transition for the customers and employees of Chiltern, with no impact in the day to day operation of the business anticipated as a result of this change in ownership.” Mr. Garnham commented, “My family is delighted to have found a buyer that understands our business so well and is committed to maintaining our high quality service offering and to our most important resource, our people, who have worked so hard for Chiltern’s success. We look forward to seeing Chiltern’s continued growth and would like to thank all our staff, suppliers and customers for their support over many years.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !